Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke.

Parnetti L, Caso V, Santucci A, Corea F, Lanari A, Floridi A, Conte C, Bottiglieri T.

Neurol Sci. 2004 Apr;25(1):13-7.

PMID:
15060810
2.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
3.

Cerebrovascular risk factors and clinical classification of strokes.

Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G.

Semin Vasc Med. 2004 Aug;4(3):287-303. Review.

PMID:
15630637
4.

Homocysteine and risk of stroke.

Perry IJ.

J Cardiovasc Risk. 1999 Aug;6(4):235-40. Review.

PMID:
10501275
5.

Is plasma homocysteine a modifiable risk factor for stroke?

Hankey GJ.

Nat Clin Pract Neurol. 2006 Jan;2(1):26-33. Review.

PMID:
16932518
6.

Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease.

Parnetti L, Caso V, Amici S, Lanari A, Gallai V, Bottiglieri T.

Clin Exp Hypertens. 2002 Oct-Nov;24(7-8):501-9. Review.

PMID:
12450225
7.

[Homocysteinemia as a risk factor for cerebrovascular disorders. The role of age and homocysteine levels].

Reis RP, Azinheira J, Reis HP, Pereira M, Baptista A, Crepo M, Pina JE, Ferreira NC, Luis AS.

Acta Med Port. 1996 Jan;9(1):15-20. Review. Portuguese.

8.

[Clinical relevance of homocysteine monitoring in the diabetic patient].

Benmerabet S, Fredenrich A, Robillon JF, Canivet B, Candito M, Van Obberghen E.

Diabetes Metab. 2002 Dec;28(6 Pt 1):510-5. Review. French.

PMID:
12522334
9.

Homocysteine, hypertension and stroke.

Perry IJ.

J Hum Hypertens. 1999 May;13(5):289-93. Review.

PMID:
10376845
10.
11.

Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke.

Sarkar PK, Lambert LA.

Int J Clin Pract. 2001 May;55(4):262-8. Review.

PMID:
11406912
12.

Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.

Asfar S, Safar HA.

J Cardiovasc Surg (Torino). 2007 Oct;48(5):601-5. Review.

PMID:
17989630
13.

Homocysteine and coronary heart disease: a review of the current evidence.

Pasceri V, Willerson JT.

Semin Interv Cardiol. 1999 Sep;4(3):121-8. Review.

PMID:
10545618
14.

Novel risk factors for stroke: homocysteine, inflammation, and infection.

Goldstein LB.

Curr Atheroscler Rep. 2000 Mar;2(2):110-4. Review.

PMID:
11122733
15.

Can lowering homocysteine levels reduce the incidence of stroke?

Sarkar PK, Lambert L.

J Clin Pharm Ther. 1999 Oct;24(5):331-8. Review. Erratum in: J Clin Pharm Ther 2000 Feb;25(1):75.

PMID:
10583695
16.

[Secondary prevention of ischemic cerebrovascular accidents].

Jerbi Z, Borsali-Falfoul N, Touir F, Hachicha Y, Chergui A.

Tunis Med. 2002;80(8 Suppl):8-13. Review. French. No abstract available.

PMID:
12698546
17.

Homocysteine and hypertension.

Yeolekar ME, Shete MM.

J Assoc Physicians India. 2002 May;50 Suppl:29-35. Review. No abstract available.

PMID:
12186153
18.

[Hyperhomocysteinemia--a risk factor or vascular disease?].

Bar-Meir E, George J, Shoenfeld Y.

Harefuah. 1999 Jan 15;136(2):129-33. Review. Hebrew. No abstract available.

PMID:
10914181
19.

Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke--pathogenic and therapeutic implications.

Banecka-Majkutewicz Z, Sawuła W, Kadziński L, Węgrzyn A, Banecki B.

Acta Biochim Pol. 2012;59(4):495-9. Epub 2012 Dec 19. Review.

20.

Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.

Dayal S, Lentz SR.

Antioxid Redox Signal. 2007 Nov;9(11):1899-909. Review.

PMID:
17822370

Supplemental Content

Support Center